Evidence map›Paper›PMID 39487145›Full record

ArticleScientific reports2024

Boosting the accuracy of existing models by updating and extending: using a multicenter COVID-19 ICU cohort as a proxy.

Daniek A M Meijs, Laure Wynants, Sander M J van Kuijk, Clarissa I E Scheeren, Anisa Hana, Jannet Mehagnoul-Schipper, Björn Stessel, Margot Vander Laenen, Eline G M Cox, Jan-Willem E M Sels and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Daniek A M MeijsDepartment of Intensive Care Medicine, Maastricht University Medical Center + (Maastricht UMC+), P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands. daniek.meijs@mumc.nl.ORCID 0000-0002-9000-0420
Laure WynantsDepartment of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands.ORCID 0000-0002-3037-122X
Sander M J van KuijkDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht UMC+, Maastricht, the Netherlands.ORCID 0000-0003-2796-729X
Clarissa I E ScheerenDepartment of Intensive Care Medicine, Zuyderland Medisch Centrum, Heerlen/Sittard, the Netherlands.
Anisa HanaDepartment of Intensive Care Medicine, Laurentius Ziekenhuis, Roermond, the Netherlands.
Jannet Mehagnoul-SchipperDepartment of Intensive Care Medicine, VieCuri Medisch Centrum, Venlo, the Netherlands.ORCID 0000-0002-9357-2950
Björn StesselDepartment of Intensive Care Medicine, Jessa Hospital, Hasselt, Belgium.ORCID 0000-0002-1422-2777
Margot Vander LaenenDepartment of Intensive Care Medicine, Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium.
Eline G M CoxDepartment of Intensive Care Medicine, Maastricht University Medical Center + (Maastricht UMC+), P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.ORCID 0000-0003-0821-7362
Jan-Willem E M SelsDepartment of Intensive Care Medicine, Maastricht University Medical Center + (Maastricht UMC+), P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.ORCID 0000-0001-7557-1594
Luc J M SmitsDepartment of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands.ORCID 0000-0003-0785-1345
Johannes BickenbachDepartment of Intensive Care Medicine, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.ORCID 0000-0002-0039-8448
Dieter MesottenFaculty of Medicine and Life Sciences, UHasselt, Diepenbeek, Belgium.ORCID 0000-0002-3258-4720
Iwan C C van der HorstDepartment of Intensive Care Medicine, Maastricht University Medical Center + (Maastricht UMC+), P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.ORCID 0000-0003-3891-8522
Gernot MarxDepartment of Intensive Care Medicine, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.ORCID 0000-0003-0866-4234
Bas C T van BusselDepartment of Intensive Care Medicine, Maastricht University Medical Center + (Maastricht UMC+), P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.ORCID 0000-0003-1621-7848
CoDaP Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most published prediction models for Coronavirus Disease 2019 (COVID-19) were poorly reported, at high risk of bias, and heterogeneous in model performance. To tackle methodological challenges faced in previous prediction studies, we investigated whether model updating and extending improves mortality prediction, using the Intensive Care Unit (ICU) as a proxy. All COVID-19 patients admitted to seven ICUs in the Euregio-Meuse Rhine during the first pandemic wave were included. The 4C Mortality and SEIMC scores were selected as promising prognostic models from an external validation study. Five predictors could be estimated based on cohort size. TRIPOD guidelines were followed and logistic regression analyses with the linear predictor, APACHE II score, and country were performed. Bootstrapping with backward selection was applied to select variables for the final model. Additionally, shrinkage was performed. Model discrimination was displayed as optimism-corrected areas under the ROC curve and calibration by calibration slopes and plots. The mortality rate of the 551 included patients was 36%. Discrimination of the 4C Mortality and SEIMC scores increased from 0.70 to 0.74 and 0.70 to 0.73 and calibration plots improved compared to the original models after updating and extending. Mortality prediction can be improved after updating and extending of promising models.

Indexed as

COVID-19Intensive Care UnitsAgedCohort StudiesFemaleHumansMaleMiddle AgedPrognosisROC CurveSARS-CoV-2

Identifiers

PMID39487145
PMCPMC11530535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.